ILCA School of Liver Cancer 2018
In-Person Event
May 18 - 19, 2018
Bologna, Emilia-Romagna, ITOVERVIEW
ILCA School of Liver Cancer is organized by International Liver Cancer Association (ILCA) and will be held during May 18 - 19, 2018 at The Hospital-University Hospital Bologna Policlinico S. Orsola-Malpighi, Bologna, Emilia-Romagna, Italy.
The target audience for this medical event is Fellows in gastroenterology and hepatology training programmes, junior faculty, basic/translational researchers and experienced clinicians with a desire to become more involved in liver cancer investigation and care.
Course Description:
The ILCA School of Liver Cancer has been launched with the aim of delivering scientific education and helping progress ILCA’s mission to advance research in pathogenesis, prevention and treatment of liver cancer.
The ILCA School is a unique learning platform for practitioners and investigators to receive education in an intense, interactive and multidisciplinary format.
This annual educational event consists of 1,5-day courses focusing on a specific topic and is hosted in a Centre of Excellence worldwide which is selected based on application.
The ILCA School provides fellows in gastroenterology, hepatology, basics/transitional researchers and other liver cancer-related professionals an opportunity to enhance their scientific experience by attending a multidisciplinary programme delivered by the most eminent international liver cancer specialists.
Participants learn about the principles and nuances of the diagnosis, management, and clinical investigation of liver cancer. The School’s intense, multidisciplinary and interactive format offers attendees state-of-the-art clinically relevant information regarding the disease.
Learning Objectives:
• Understanding the new systemic therapies indicated for HCC and the perspectives for the drugs to come
• Identifying the most promising circulating miRNA for diagnosis and staging of HCC
• Understanding how often HCC develops in non-alcoholic fatty liver disease without cirrhosis and which are the hypothesis, genetic and clinical factors associated with higher risk of HCC onset in the absence of cirrhosis
• Recognising the diagnostic dilemmas the radiologist encounter when the pattern of a small liver nodule is not typical for HCC and the LI RADS classification system
• Understanding the innovative surgical and locoregional approach to the treatment of cholangiocarcinoma
Additional details will be posted as soon as they are available.
The target audience for this medical event is Fellows in gastroenterology and hepatology training programmes, junior faculty, basic/translational researchers and experienced clinicians with a desire to become more involved in liver cancer investigation and care.
Course Description:
The ILCA School of Liver Cancer has been launched with the aim of delivering scientific education and helping progress ILCA’s mission to advance research in pathogenesis, prevention and treatment of liver cancer.
The ILCA School is a unique learning platform for practitioners and investigators to receive education in an intense, interactive and multidisciplinary format.
This annual educational event consists of 1,5-day courses focusing on a specific topic and is hosted in a Centre of Excellence worldwide which is selected based on application.
The ILCA School provides fellows in gastroenterology, hepatology, basics/transitional researchers and other liver cancer-related professionals an opportunity to enhance their scientific experience by attending a multidisciplinary programme delivered by the most eminent international liver cancer specialists.
Participants learn about the principles and nuances of the diagnosis, management, and clinical investigation of liver cancer. The School’s intense, multidisciplinary and interactive format offers attendees state-of-the-art clinically relevant information regarding the disease.
Learning Objectives:
• Understanding the new systemic therapies indicated for HCC and the perspectives for the drugs to come
• Identifying the most promising circulating miRNA for diagnosis and staging of HCC
• Understanding how often HCC develops in non-alcoholic fatty liver disease without cirrhosis and which are the hypothesis, genetic and clinical factors associated with higher risk of HCC onset in the absence of cirrhosis
• Recognising the diagnostic dilemmas the radiologist encounter when the pattern of a small liver nodule is not typical for HCC and the LI RADS classification system
• Understanding the innovative surgical and locoregional approach to the treatment of cholangiocarcinoma
Additional details will be posted as soon as they are available.
KEY DATES
18 May, 2018
Event Start Date
19 May, 2018
Event End Date
SPECIALITIES
OncologySUGGESTED HOTELS
CONFERENCE VENUE
The Hospital-University Hospital Bologna Policlinico S. Orsola-MalpighiRELATED CONFERENCES & LIVE WEBINARS
Quick Links